Company Search:
Advanced Search
Sponsored Links
Cumberland Pharmaceuticals Incorporation Company Snapshot
Cumberland Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cumberland Pharmaceuticals Incorporation with three other companies in this sector in UNITED STATES : Harrow Health Inc (2019 sales of $51.17 million of which 100% was Pharmaceutical Compounding), Integrated Biopharma, Inc. ($49.98 million ), and TherapeuticsMD Incorporated ($49.65 million of which 100% was Creating and commercializing products).

Sales Analysis. Cumberland Pharmaceuticals Incorporation reported sales of $47.53 million for the year ending December of 2019. This represents an increase of 16.7% versus 2018, when the company's sales were $40.74 million. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 266.2% in 2019, from $540,933.00 to $1.98 million. Cumberland Pharmaceuticals Incorporation also saw significant increases in sales in Vibativ (up 71.3% to $8.69 million) and Omeclamox-Pak (up 34.4% to $837,829.00 ) . Not all segments of Cumberland Pharmaceuticals Incorporation experienced an increase in sales in 2019: sales of Totect fell 56.5% to $369,912.00 . (However, this segment's sales were only a very small portion of the company's overall sales). Cumberland Pharmaceuticals Incorporation also experienced decreases in sales in Acetadote (down 10.7% to $3.82 million) and Vaprisol (down 46.9% to $936,615.00 ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cumberland Pharmaceuticals Incorporation
  Stock Performance Chart for Cumberland Pharmaceuticals Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 3.54
(Figures in U.S. Dollars)
1 Week -3.8%   13 Weeks -10.4%  
4 Weeks -21.3%   52 Weeks -44.7%  
Cumberland Pharmaceuticals Incorporation Key Data:
  Ticker: CPIX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 47,533,637
(Year Ending Jan 2020).
Employees: 94
  Currency: U.S. Dollars Market Cap: 54,227,593
  Fiscal Yr Ends: December Shares Outstanding: 15,318,529
  Share Type: Common Closely Held Shares: 6,392,014
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.